You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Papillary, Follicular

Showing 1 - 25 of 9,381
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Papillary, Follicular Trial in Seoul (Using Neuromonitoring to find EBSLN)

Terminated
  • Carcinoma, Papillary, Follicular
  • Using Neuromonitoring to find EBSLN
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 13, 2022

Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

Active, not recruiting
  • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
  • +25 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Torrance, California
  • +6 more
Jan 12, 2023

18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

Recruiting
  • Differentiated Thyroid Gland Carcinoma
  • +2 more
  • Computed Tomography
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma

Recruiting
  • Refractory Thyroid Gland Carcinoma
  • +3 more
  • 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
  • +2 more
  • Xiamen, China
    The First Affiliated Hospital of Xiamen University
Nov 3, 2022

Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

Not yet recruiting
  • Thyroid Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 20, 2022

Surgical Management of Advanced Thyroid Cancer

Recruiting
  • Thyroid Carcinoma
  • +6 more
  • Thyroidectomy with or without lymphadenectomy or multivisceral resection
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 31, 2023

Benign Thyroid Gland Tumor, Recurrent Thyroid Gland Carcinoma, Thyroid Gland Follicular Tumor of Uncertain Malignant Potential

Recruiting
  • Benign Thyroid Gland Neoplasm
  • +4 more
  • Quality-of-Life Assessment
  • Radiofrequency Ablation
  • Houston, Texas
    M D Anderson Cancer Center
Sep 3, 2022

Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

Recruiting
  • Thyroid Cancer
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 19, 2023

Metastatic Thyroid Papillary Carcinoma, Metastatic Thyroid Follicular Carcinoma, Metastatic Thyroid Cancer Trial in Spain

Recruiting
  • Metastatic Thyroid Papillary Carcinoma
  • +2 more
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +14 more
Feb 18, 2022

Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)

Terminated
Has Results
  • Thyroid Cancer
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021

Galectin-3 in Papillary Thyroid Carcinoma

Not yet recruiting
  • Galactin 3-thyroid Carcinoma
    • (no location specified)
    Jan 26, 2023

    Differentiated Thyroid Gland Carcinoma, Thyroid Gland Follicular Carcinoma, Thyroid Gland Papillary Carcinoma Trial in Atlanta

    Terminated
    • Differentiated Thyroid Gland Carcinoma
    • +2 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Jun 25, 2021

    Thyroid Carcinoma, Thyroid Cancer, Thyroid Cancer, Follicular Trial in United States (I-124 PET/CT lesion dosimetry,

    Recruiting
    • Thyroid Carcinoma
    • +5 more
    • I-124 PET/CT lesion dosimetry
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Mar 3, 2022

    Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

    Recruiting
    • Thyroid Cancer
    • +2 more
      • Taipei, Taiwan
        Chih-Yuan Wang, M.D
      Oct 16, 2022

      Thyroid Tumors Trial in Worldwide (Vandetanib, Placebo)

      Active, not recruiting
      Has Results
      • Thyroid Neoplasms
      • Brussels, Belgium
      • +21 more
      Oct 20, 2021

      Papillary Thyroid Carcinoma, Thermal Ablation Trial in Beijing (No Intervention)

      Recruiting
      • Papillary Thyroid Carcinoma
      • Thermal Ablation
      • No Intervention
      • Beijing, China
        Beijing Friendship Hospital
      Jul 19, 2023

      Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

      Not yet recruiting
      • Papillary Renal Cell Carcinoma
      • (no location specified)
      Nov 24, 2023

      Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma

      Completed
      • Huerthle Cell Carcinoma
        • (no location specified)
        Jul 20, 2023

        Tumor Deposits for Patients With Papillary Thyroid Carcinoma

        Completed
        • Exploring the Prognostic Value of Tumor Deposits PTC Patients
        • surgery
        • Guangzhou, Guangdong, China
          Nanfang Hospital, Southern Medical University
        Sep 18, 2023

        Asymptomatic Papillary Microcarcinomas on Patient Survival

        Active, not recruiting
        • Papillary Carcinoma
        • Questionnaire
        • Toulouse, France
          UHToulouse
        May 15, 2023

        Thyroid Cancer, Surgery, Recurrence Trial in Beijing (Thyroxine)

        Recruiting
        • Thyroid Cancer
        • +2 more
        • Beijing, Beijing, China
          Cancer Hospital, Chinese Academy of Medical Science
        Oct 13, 2023

        Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma

        Completed
        • Carcinoma, Renal Cell
        • We do not have any interventions. This study is based on obseravation.
        • (no location specified)
        Oct 27, 2023

        Fascial Versus Standard Neck Dissection in N1b Papillary Thyroid

        Completed
        • Patients With Papillary Thyroid Cancer and N1b Status
        • Fascial Neck Dissection
        • Standard Neck Dissection
        • Rome, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Mar 27, 2023

        Carcinoma, Renal Cell Trial (Orellanine)

        Not yet recruiting
        • Carcinoma, Renal Cell
        • (no location specified)
        Jan 25, 2023

        Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

        Not yet recruiting
        • Advanced Clear Cell Renal Carcinoma (Ccrcc)
        • Papillary Renal Cell Carcinoma (Prcc)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023